Genomic Health, Inc. - GHDX - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 26, 2013

Genomic Health, Inc. - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
GHDX	Nasdaq	8731	http://www.genomichealth.com/	37.00 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Genomic Health, Inc. 6 Ways You Can Profit From Molecular Diagnostics - May 22nd, 2013 8:00 am Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 21st, 2013 6:00 am Genomic Health Director Buys More Than 52K Shares and 4 Insider Trades to Note - May 17th, 2013 9:34 am In Insider Trading, Harbinger Buys Spectrum Brands Stock for 11th Time Since April 9 - May 17th, 2013 9:17 am Hecla Mining CEO Buys 150K Shares and 4 Insider Trades to Note - May 16th, 2013 8:10 am The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals - May 16th, 2013 5:51 am Genomic Health's New Prostate Test May Extend The Stock's Upward Climb - May 15th, 2013 4:27 pm New cancer tools allow patients to reconsider chemo - May 15th, 2013 3:59 pm Much Awaited Test Launch by Genomic - May 15th, 2013 12:30 pm 5 Stocks Insiders Love Right Now - May 15th, 2013 10:45 am An Insider Sells Major Stake of General Growth Properties While Directors at Genomic Health and US Steel Buy Stock - May 15th, 2013 8:23 am U.S. Steel Director Buys More Than 72K Shares and 4 Insider Trades to Note - May 15th, 2013 7:01 am 3 Disruptive Technologies That Could Slash Health-Care Costs - May 14th, 2013 3:45 pm Myriad Genetics climbs after Jolie reveals genetic testing - May 14th, 2013 10:00 am Genomic Gains Coverage for DCIS - May 13th, 2013 11:50 am GENOMIC HEALTH INC Files SEC form 8-K, Other Events - May 13th, 2013 8:02 am GENOMIC HEALTH INC Financials - May 11th, 2013 11:04 am Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) Diagnosis - May 10th, 2013 2:02 pm Genomic Health Inc Stock Sees Short Interest Jump 12% - May 10th, 2013 1:56 pm Tech That Disrupts Our Lives for the Better - May 10th, 2013 12:32 pm View All Current Headlines >>